|
Top : For Professionals Only : Page 2
CF Resources: For Professionals Only
Categories:
Links:
- Eradication of initial P. aeruginosa colonization in pts with CF (2002)
- The optimal treatment for the eradication of initial P. aeruginosa infection in CF is still unclear. Recently long-term inhaled tobramycin has been proposed. Here we report the results with brief inhaled and/or systemic anti-pseudomonal treatments. Initial P. aeruginosa colonization was successfully eradicated as demonstrated by negative repetitive throat cultures or sputa and serum antipseudomonal antibodies in 15 of 17 patients for at least two years.
(Added: 2-Dec-2002 Hits: 40 Rating: 0 ) Rate It
- Hypertonic Saline (2002)
- Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis
(Added: 2-Dec-2002 Hits: 54 Rating: 0 ) Rate It
- Initial P. aeruginosa colonization in pts with cystic fibrosis (2002)
- Report of the results with brief inhaled and/or systemic anti-pseudomonal treatments. Initial P. aeruginosa colonization was successfully eradicated as demonstrated by negative repetitive throat cultures or sputa and serum antipseudomonal antibodies in 15 of 17 patients for at least two years.
(Added: 23-Oct-2002 Hits: 26 Rating: 0 ) Rate It
- KidsHealth
- Good information source for teachers
(Added: 24-Aug-2002 Hits: 27 Rating: 0 ) Rate It
- LifeScan Professionals
- We also offer health care professionals that treat patients with diabetes additional information and resources to help you improve the quality of life for your patients with diabetes.
(Added: 21-Aug-2002 Hits: 28 Rating: 0 ) Rate It
- Lispro (Human Analog) (entered 2002)
- Humalog (insulin lispro, rDNA origin) is a human insulin analog that is a rapid-acting, parenteral blood glucose-lowering agent. Chemically, it is Lys(B28), Pro(B29) human insulin analog, created when the amino acids at positions 28 and 29 on the insulin B-chain are reversed. Humalog is synthesized in a special non-pathogenic laboratory strain of Escherichia coli bacteria that has been genetically altered by the addition of the gene for insulin lispro.
(Added: 2-Dec-2002 Hits: 19 Rating: 0 ) Rate It
- Listen To Us
- One of the most important things to learn with medicine, is you MUST listen to your patient. Particularly those of us with CF. We have lived with our diseases and know our bodies. No, we aren't doctors, but some of us should have honorary degrees with all we know about medicine.
(Added: 5-Dec-2002 Hits: 45 Rating: 0 ) Rate It
- Nasally inhaled dornase alfa
- Nasally inhaled dornase alfa in the postoperative management of chronic sinusitis due to cystic fibrosis.
(Added: 18-Sep-2002 Hits: 12 Rating: 0 ) Rate It
- Orphan Drug Designation for Aztreonam For Inhalation Therapy (2002)
- Corus Pharma announced that Corus 1020
(aztreonam) has been granted orphan drug designation by the U.S. Food and Drug
Administration (FDA) for inhalation therapy for control of gram-negative
bacteria in the respiratory tract of patients with cystic fibrosis. Corus 1020 is an antibiotic that has a broad spectrum of activity against
gram-negative bacteria. Inhaled antibiotics effectively treat gram-negative
infections in patients with cystic fibrosis because of the higher local
concentrations of drug at the site of infection.
(Added: 23-Oct-2002 Hits: 13 Rating: 0 ) Rate It
Prev 20
Next 20
Pages Updated On: 27-Sep-2005 - 04:46:50
Links Engine 2.0 By: Gossamer Threads Inc.
The Cystic Fibrosis-Reaching Out Foundation is a non-profit Foundation under Section 501 (c) 3 of the Internal Revenue Code. Accordingly, the Foundation is not required to pay income taxes. Donors may deduct contributions to the Cystic Fibrosis-Reaching Out Foundation Inc, only to the extent that their contributions are gifts, with no consideration given.
|
